<DOC>
	<DOCNO>NCT00540631</DOCNO>
	<brief_summary>Multicenter Immunotherapy House Dust Mite Allergoid</brief_summary>
	<brief_title>Multicenter Trial Immunotherapy With House Dust Mite Allergoid</brief_title>
	<detailed_description>A multicentre randomized placebo-controlled double-blind clinical trial evaluation safety efficacy specific immunotherapy aluminium hydroxide-adsorbed allergoid preparation house dust mite ( Dermatophagoides pteronyssinus ) patient rhinitis/rhinoconjunctivitis and/or allergic asthma bronchiale</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>Positive SPT Positive EAST Positive specific provocation test Serious chronic diseases perennial allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>House Dust Mite Allergen</keyword>
	<keyword>Aluminium hydroxide-adsorbed</keyword>
</DOC>